glp-1 drug mounjaro FDA approves new version of diabetes to be sold for weight loss GLP-1 Drug Overdose
Description
While the drug isnt currently approved by the FDA for weight loss, it shows promise for improving weight maintenance for people with obesity or overweight

Outcomes: AUD diagnosis and/or alcohol-related hospitalization, preferentially reported as hazard ratios (HRs) with 95% confidence intervals (CIs)

Tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away severe stomach problems

Time to implement the #4pillars of kidney GDMT - RAS blockade - SGLT2i - ns-MRA - GLP-1 RA Lifetime cardiovascular, kidney & mortality benefits of combination therapy in people with diabetes with albuminuria Now #openaccess in @CircAHA for #AHA23 ahajournals.org/doi/10.1161/CI Time to implement the #4pillars of kidney GDMT - RAS blockade - SGLT2i - ns-MRA - GLP-1 RA Lifetime cardiovascular, kidney & mortality benefits of combination therapy in people with diabetes with albuminuria Now #openaccess in @CircAHA for #AHA23 ahajournals.org/doi/10.1161/CI

a Effectiveness is based on average excess weight loss (EWL) or total body weight loss (TBWL) over the indicated time period

How could this happen he wondered
